Symptomatic treatment of bronchial asthma

In a study on bronchial asthma, 40% of patients were found to use rapid symptomatic treatment, putting their health at risk.
Almost two thousand seven hundred people with asthma were interviewed in the study. The researchers found that 39% of them were only using symptomatic medications that simply treat asthma symptoms, rather than long-acting prophylactic medications. The authors are concerned about this, because these patients have to seek treatment when their condition dangerously worsens at the last minute. Treatment with such drugs is just an option for people with mild asthma. Only patients who have infrequent asthma symptoms, use their inhaler less than twice a month, and who have no risk factors for asthma flare-ups can use this symptom-only approach. The study found that patients who were more likely to use such drugs were more likely to be men and smokers. One in nine Australians suffer from asthma, a total of about 2.5 million people. According to experts, the disease most often occurs in men under the age of fourteen, but among those aged fifteen years and older, asthma is more common in women. Preventive drugs help control asthma symptoms and prevent attacks. They reduce inflammation in the airways, making them less sensitive. Researchers said the results of the study showed a worrying picture of living with asthma in many of those who only use an inhaler. Patients experience short-term relief and this treatment does nothing to address the underlying problem. This group of patients tend to be very upset with their illness and dissatisfied with how they are managing their asthma. They are also more likely to live in fear of a severe asthma attack despite taking their medications as directed. Many of the patients stated that they were more likely to manage the attack themselves rather than seek medical attention. Many adults with asthma take preventive medications, usually in the form of an inhaler, which delivers a low dose of corticosteroids to the lungs. Asthma death rates and hospital admissions in Australia have dropped sharply since 1990. But the study found that some doctors and patients were unduly reassured by the severity of the condition. The authors believe that Australia needs urgent changes in both drug prescribing and drug recommendations to protect thousands of Australians from serious health problems from poorly managed asthma.

event_note February 24, 2022

account_box Kroll

Leave a Reply

Your email address will not be published. Required fields are marked *